Next quarter’s earnings estimate for IGC is -$0.03 with a range of -$0.03 to -$0.03. The previous quarter’s EPS was -$0.02. IGC beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 56.92% of the time in the same period. In the last calendar year IGC has Underperformed its overall industry.

IGC Sales Forecast

Next quarter’s sales forecast for IGC is $200.00K with a range of $200.00K to $200.00K. The previous quarter’s sales results were $412.00K. IGC beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 46.51% of the time in the same period. In the last calendar year IGC has Outperformed its overall industry.

Detailed List of Analyst Forecasts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Edward Woo

Ascendiant

$3.5→$3.75

Buy

889.45%

Upside

Reiterated

08/31/24

We are adjusting our FY25 estimates for revenue to $1.1 million, from $1.5 million, and for EPS to $(0.13) from $(0.12). Reported positive interim results: On March 20, IGC reported results of an interim analysis of its ongoing Phase 2 trial for IGC-AD1 as a treatment for Agitation in dementia from Alzheimer’s Disease (AAD). The interim data demonstrates a clinical and statistically significant reduction in agitation compared to placebo in patients with Alzheimer’s disease. This and additional positive data may allow the company to speed up its current clinical trials and FDA approval pathways.

James Molloy

Alliance Global Partners

$3.5

Buy

823.48%

Upside

Initiated

07/17/24

IGC Pharma initiated with a Buy at Alliance Global PartnersIGC Pharma initiated with a Buy at Alliance Global Partners

Best Analysts Covering IGC Pharma

Which Analyst Should I Follow If I Want to Buy IGC and Sell After:

1 Month

xxx

Success Rate

2/3 ratings generated profit

Average Return

+1.93%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +1.93% per trade.

3 Months

xxx

Success Rate

2/3 ratings generated profit

Average Return

+19.60%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +19.60% per trade.

1 Year

Edward WooAscendiant

Success Rate

2/3 ratings generated profit

Average Return

+1.27%

reiterated a buy rating 4 months ago

Copying Edward Woo's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +1.27% per trade.

2 Years

xxx

Success Rate

2/3 ratings generated profit

Average Return

+1.27%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +1.27% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

IGC Analyst Recommendation Trends

Rating

Feb 24

Jul 24

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, IGC has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IGC average Analyst price target in the past 3 months is ―.

Each month's total comprises the sum of three months' worth of ratings.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

IGC Stock Forecast FAQ

What is IGC’s average 12-month price target, according to analysts?

Currently, no data Available

What is IGC’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for IGC, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is IGC a Buy, Sell or Hold?

Currently, no data Available

What is IGC Pharma’s price target?

Currently, no data Available

What do analysts say about IGC Pharma?

Not enough analysts have published a price target to provide an average price target.

How can I buy shares of IGC?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

IGC Pharma (IGC) Stock Forecast & Price Target

IGC Analyst Ratings

IGC Stock 12 Month Forecast

IGC Financial Forecast

IGC Earnings Forecast

IGC Sales Forecast

Detailed List of Analyst Forecasts​

Best Analysts Covering IGC Pharma

IGC Analyst Recommendation Trends

IGC Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts